Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Low-Grade Glioma Management
ASCO Educational Book
- IDH1/2 and BRAF are frequently altered, should be tested in all patients
- IDH inhibitor therapy may be considered in patients who have not received radiation or chemotherapy
- BRAF inhibitor therapy is an appropriate first line for patients with BRAF V600E-altered low-grade glioma.”
Read further.
Source: Erman Akkus/X
